SmallCapInvestor.com
Search
Advanced Search
Quote
Company Search

Independent Small Cap News, Research, and Insights

Home Small Cap News Investing Strategies Industries Stock Research Personal Finance My Stuff
Industries

Newsletter Watch: Enzon Pharmaceuticals

This week, we examine biotechnology expert Marc Lichtenfeld’s investing strategy as well as his recent stock pick of Enzon Pharmaceuticals, Inc. (Nasdaq:ENZN).


Sector Watch: An apple, or pill, a day

Newsletter Watch: Biotech stocks

Emergent BioSolutions: What, me worry?

Interview with Mary Lisanti

Clinical trial fails for Keryx Biopharmaceuticals

Sciele Pharma: A Sular eclipse

PharmaNet Development Group plunges on weak 2008 forecast

Acorda Therapeutics soars on trial results

NVE Corp. clocks robust Q3

MiddleBrook Pharmaceuticals receives FDA OK for drug

Orexigen Therapeutics prices public offering

NMT Medical to terminate MIST II trial

Northstar Neuroscience says Everest trial fails

FDA OKs Celsion's liver cancer trial

Newsletter Watch: PURE Bioscience

Lifecore Biomedical to be acquired by PE firm, reports Q2 results below the Street

Pharmasset soars on positive clinical trial results

Osiris Therapeutics rises on $225 million DoD contract

Metabasis Therapeutics reports positive results for Phase 1b trial

Sciele Pharma receives FDA approval for Sular formulation

GenVec reaches agreement with FDA

IPO Watch: Elixir Pharmaceuticals

Salix Pharmaceuticals sputters on generic competition

Dendreon gains on CNBC tout

Cell Therapeutics rises on drug contract

Encysive Pharmaceuticals issues revenue guidance, exploring strategic alternatives

Rigel Pharmaceuticals hits 52-week high after successful drug test

Dendreon soars on news of Congressional investigation

Geron receives $4M payment from Merck for IND application

Cardiome Pharma receives approval of Kynapid

Sequenom, Inc.: Big genes to fill

AVANIR Pharmaceuticals soars after swinging to Q4 profit

Vion Pharmaceuticals gains on positive Phase II data

Hemispherx Biopharma calls off licensing agreement with Esteve

2008 looks to be more optimistic for small-cap specialty pharma companies

Synta Pharmaceuticals receives cash payment from Glaxo

Rockwell Medical Technologies receives FDA OK for drug-delivery product

Neurobiological Technologies rises, will treat Huntington's disease

AVI BioPharma rises on FDA fast-track status

Cell Therapeutics, Inc. to offer $6.5M convertible preferred stock

Penwest Pharmaceuticals rises on options activity

Indevus Pharma reports positive results from octreotide implant Phase II trial

Osiris Therapeutics rises on positive stem-cell treatment results

AspenBio Pharma soars on FDA news

FDA accepts Vanda Pharmaceuticals NDA

Sinovac Biotech gains on clinical trials for flu vaccines

Cyberonics posts narrower FY08 Q2 loss

Discovery Laboratories higher as FDA agrees to review drug

Repligen Corp.: All you need is cash

Check on China: 3SBio Inc.

3SBio Inc. records robust Q3

ISTA Pharmaceuticals jumps on positive drug trial

Novavax' Q3 widens from year ago, clocks below expectations

GeoPharma receives FDA approval for dog drug

Chelsea Therapeutics International receives OK from FDA

DUSA Pharmaceuticals clocks narrower-than-expected Q3 loss

Neurogen narrows Q3 loss

Nastech Pharmaceutical terminates agreement with P&G, reclaims nasal spray rights

Acadia Pharmaceuticals stumbles on Q3 earnings miss

FDA rejects Momenta Pharmaceuticals' partner's drug

Micromet studies show activation of T cells when cancer cells are present

Tapestry Pharmaceuticals plummets on 69% Q3 profit decline

IDM Pharma says program for treatment of osteosarcoma is safe

Newsletter Watch: Immtech Pharmaceuticals, Inc.

Dynavax Technologies Corp. inks licensing agreement with Merck, posts sour Q3

Neurocrine Biosciences inks sale and leaseback agreement with Veralliance Properties

Savient Pharmaceuticals down after swinging to Q3 loss

Kosan Biosciences to end cancer collaboration with Roche

Newsletter Watch: Genomic Health, Inc.

Pharmasset receives fast track designation

MediciNova's clinical trial for insomnia fails

GenVec completes sixth option period with NIH

Enzo Biochem up on improved Q4 results

Immunomedics up on patent award

Anesiva reports positive Phase 3 trial of 'Zingo' in adults

Medis Technologies receives order from General Dynamics

Memory Pharmaceuticals falls to 52-week low

Memory Pharmaceuticals says Phase 2 trial for Alzheimer's disease fails

Via Pharmaceuticals Inc. higher, receives OK for drug tests

MAP Pharmaceuticals Inc. rises, additional shares purchased

Acusphere clears rumors, says 'Imagify' is safe

Noven Pharmaceuticals says Lithium Phase 3 trail fails

Avanir Pharmaceuticals reaches agreement with FDA

EpiCept Corp. successfully completes Phase 1

Oxigene announces positive interm Phase Ib results

Hollis-Eden Pharmaceuticals up, cancer drug promising

Penwest Pharmaceuticals falls on patent challenge

Targeted Genetics receives milestone payment

Aastrom Biosciences reports positive interim results for two trials

PerkinElmer acquires ViaCell for $300M

Adventrx Pharmaceuticals trial for colorectal cancer fails

American Oriental Bioengineering: Ancient Chinese secrets meet modern Western medicine

ImmunoGen to present clinical data soon

Bioenvision Inc. lower, Genzyme reaffirms offer

Javelin Pharmaceuticals granted patent

SIGA Technologies' smallpox drug shows 100% protection

Emergent BioSolutions inks $448M contract

Phase 1 trial initiated on Pharmacopeia's drug

Spire Corp. receives order, rises to new 52-week high

Progen Pharmaceuticals Phase 2 trial fails

Sirtris Pharmaceuticals shares rise on study results

Roche halts Maxygen's development trial for treatment of Hepatitis

BioCryst Pharmaceuticals down after disappointing flu trial

GenVec publishes pre-clinical research that may lead to cancer cures

Evotec acquires Renovis

Gene Logic to team up with FDA on genomic data

Newsletter Watch: Big gains from "small" ideas

Concept Therapeutics rise to new 52-week high on FDA nod

VeriChip lower on report that impant chips induced tumors in lab mice

Pharmasset rises on positive drug results

Omrix Bio higher on news of FDA approval for blood-clotting drug

Adolor: FDA accepts new drug application letter

Geron Corp. higher on stem cell heart news

Hana Biosciences receives fast track designation from FDA

Targeted Genetics Corp. reports positive Phase 2 data for vaccine candidate

Advanced Life Sciences Holdings, Inc. to conduct study with NIAID

Kensey Nash Corp. lower on Q4 loss

Possis Medical up on higher Q4 revenue guidance

Pre-market: Accredited Home Lenders Holding Co., Local.com Corp., Carmike Cinemas, Inc. lead small-cap Wednesday volume

Cytori Therapeutics narrows Q2 loss, beats expectations

An interview with Gene Marcial

Retail sales boost stocks

Bradley Pharmaceuticals up despite missing Q2 estimates

Novavax, Inc. reports net loss for Q2, beats by penny

Home Diagnostics, Inc. falls after Q2 results miss estimates

Spectrum Pharmaceuticals, Inc. gets FDA OK on investigational drug

Vivus, Inc. receives milestone payment from KV Pharma

EPIX Pharmaceuticals Q2 loss widens

Avanir Pharmaceuticals jumps on sale of antipsychotic drug to Azur Pharma

Indevus Pharmaceuticals, Inc. receives FDA OK for sanctura drug

PharmaNet Development Group misses Q2 income projections

Pozen plunges on second FDA rejection

Hana Biosciences, Inc. gains on deal with Par Pharmaceutical

CryoLife Inc. to move forward on BioFoam product

Auxilium Pharmaceuticals gains on higher revenues and narrower loss

SAP founder augments stake in GPC Biotech AG

FDA approves Vivus’ Evamis

Matria Healthcare, Inc misses Q2 estimates, revises guidance

Dyax Corp. misses Q2 estimates

Cell Therapeutics, Inc. buys Systems Medicine Co.

Neurochem Inc. gains on FDA’s fast track designation

Panacos Pharmaceuticals: Attacking HIV

Russell falls as earnings lift Dow

The bulls get stronger

Wall Street gaining

IDM Pharma Inc to revise New Drug Application

Russell 2000 ready to rise

BSD Medical Corp. continues to fall despite company comments

Spectrum Pharmaceuticals, Inc plunges on FDA skepticism

NUCRYST Pharmaceuticals Corp soars on FDA clearance

Acorda COO to step down

Newsletter Watch: A "bird flu" play

Wednesday small-cap pre-market volume leaders: i2 Technologies Inc., StealthGas Inc., Local.com Corp.

Pre-market: Traffix beats Q2 revenue expectations

Another record for Russell 2000

Russell 2000 on track for record

Oscient trades lower on Q2 revenue estimates

Pre-market: Semitool expects Q3 loss

Dow Jones Industrial Average rises above record

Pre-market: Ariad Pharmaceuticals inks deal with Merck

A small rise on Wall Street

Russell 2000 unchanged

Hi-Tech Pharmacal swings to a loss in Q4

Pre-market: Novacea gets $60 million

Russell crumbles

Russell 2000 leads bear parade

Pre-market: Ocean Bio-Chem raises Q2 sales

SEC names small-cap companies to controversial terror list

Wall Street flat

Pre-market: Alnylam Pharmaceuticals signs $1 billiob deal

Pre-market: Mannatech Inc. being investigated

Bears gain strength

Jones Soda Co. leads Thursday small-cap pre-market trading

China Sunergy Co. continued to experience tight supplies in Q2

Local.com Corp. leads Tuesday small-cap pre-market volume

Russell 2000 flying high

Trump Entertainment Resorts, Inc. leads Monday small-cap percentage losers

A higher opening

Pre-market: Local.com awarded patent

Local.com Corp. leads Monday small-cap pre-market volume

Wall Street rising

Pre-market: Rural/Metro gets $30 million contract

Panacos Pharmaceuticals jumps after closing loan agreement

Mixed closes after rate report

Russell 2000 holding on

Russell gains as Dow stays

Pre-market: Build-A-Bear to increase stores

Russell finishes strong

Spectrum Control, Inc. leads Wednesday small-cap percentage gainers

Pre-market: Vasogen gets FDA thumbs up

Russell 2000 strikes out

Kewaunee Scientific Corp. leads Tuesday small-cap percentage gainers

Russell 2000 up, down

GeoPharma sees profitable growth opportunities in pipeline for second half of 2007

GeoPharma posts strong results in Q4, fiscal 2007

Russell 2000 the lone loser

Pre-market: Encysive Pharmaceuticals downsizes

Pre-market: Alliance Fiber Optics raises Q2 guidance

Bears running the show

Smith Micro Software, Inc. leads Friday small-cap percentage gainers

Insulet shares flat after wider loss, revenue jump

Hoku Scientific Inc. leads Friday small-cap pre-market volume

Bulls regain some ground

Winds Industries Inc. leads Thursday small-cap percentage gainers

A tussle on the Russell

Pre-market: Hoku Scientific inks $185 million contract

Telestone Technologies Corp. leads Thursday small-cap pre-market volume

New 52-week highs

LSI Industries, Inc. leads Wednesday's small-cap percentage gainers

Lower opening on Wall Street

LSI Industries raises Q4 guidance

Altra Holdings leads Wednesday's small-cap pre-market volume

New 52-week lows

Russell 2000 flat

Bakers Footwear Group, Inc. leads Tuesday small-cap percentage losers

Zila reports Q3 loss

Russell 2000 biggest loser

Pre-market: Philips buys Color Kinetics

Dow and Russell 2000 drop

Pre-market: Stemcells completes trial enrollment

Jones Soda Co. leads Monday small-cap pre-market volume

Acusphere closes warrant offering

Build-A-Bear Workshop, Inc. leads Friday small-cap percentage losers

Pre-market: EpiCept up on drug results

Inflation data lifts Wall Street

Russell 2000 leads the bulls

Hoku Scientific, Inc. leads small-cap pre-market volume

Intricon Corp. leads Wednesday small-cap percentage losers

Russell 2000 leads rally

Retail sales fuel Russell rally

Pre-market: Megal Security expands to Brazil

Russell 2000 sinks as bonds soar

Chemgenex Pharmaceuticals tops Tuesday small-cap percentage losers

On strong sales, MFRI Inc. leads Tuesday small-cap percentage gainers

Russell 2000 down, narrows losses

Pre-market: Vical Inc. receives $6 million grant

Russell 2000 left behind

Russell slips into negative territory

Pre-market: Back Yard Burgers goes private

Alfacell widens losses

Home Solutions of America, Inc. leads Friday pre-market volume

Thursday after hours

Oculus Innovative Sciences says it’s focused on FDA trial and partnerships

Russell adds to losses

Span-America Medical Systems, Inc. leads Thursday small-cap percentage losers

Stocks tumble as Treasury yields rise

Avici Systems, Inc. leads Thursday small-cap pre-market volume

Wednesday after hours

A second day of losses

Stocks sagging on inflation worries

Pre-market: Volterra Semiconductor lowers guidance

ACADIA Pharmaceuticals Inc. leads Wednesday small-cap pre-market volume

Russell takes a break

Stocks lower on inflation concerns

Pre-market: Sigma Designs raises Q1 profit

Rackable Systems, Inc. leads small-cap pre-market volume

Pre-market: Cray to fall flat in 2007

Russell 2000: Thrice is nice

Finlay Enterprises leads Friday percentage gainers

Russell 2000 races ahead

Pre-market: FDA denies Labopharm

Labopharm leads Friday pre-market volume

Newsletter Watch: Targeting Targacept

Thursday after hours: Labopharm down 47% to $3.30

Novacea, Inc. leading Thursday small-cap percentage losers

Pre-market: Optium's outlook disappoints

Novacea leads Thursday small-cap pre-market volume

Wednesday after hours

Rally to records

Nothing but red

Bioenvision leads Wednesday pre-market volume

Pre-market: Synovis profitable in Q1

Tuesday after hours

Dow falls but Russell 2000 holds on

Stocks rising

Bioenvision, Inc. leads pre-market activity

The bulls are staying

Enova Systems leading small-cap percentage gainers

The rally continues

Small-cap momentum plays

North American Galvanizing & Coatings leading small-cap percentage losers

Russell 2000 falling

Pre-market: PacificNet narrows profit

La Jolla Pharmaceutical Company leads pre-market activity

Value Find: Nabi Biopharmaceuticals

Wednesday after hours

Stocks slump on Greenspan remarks

Possis Medical missed 4Q expectations

The Wet Seal profitable in Q1

Cypress Biosciences, Inc. leads small-cap pre-market volumes

On track for records

Russell 2000 in record territory

Spectrum Pharma announces pain drug findings

Monday after hours

Odyssey Marine Exploration tops Monday small-cap volume leaders

Almost, but no record

Luna Innovations leads small-cap percentage gainers

Voxware, Inc. leading percentage losers

Home Solutions of America, Inc. tops pre-market most-actives

Russell 2000 jumps as Dow hits record

Russell 2000 joins the party

Pre-market: CalAmp Corp. downgraded as profit falls

Pre-market: DUSA Pharmaceuticals gets FDA nod

Agile Software Corp. leading Wednesday small-cap volumes

Bulls come back

Pre-market: Oracle buys Agile Software

Modest gains to start the week

Pre-market: Critical Therapeutics gets FDA approval

Biodel strong in debut

Javelin shares down on $39.3M public offering

Russell 2000 up sharply

Russell 2000 down 1 percent

Wall Street flat

Trio Tech leads small-cap percentage gainers

Somaxon stock plummets on drug delay

Pre-market: Ascent Solar gets government contract

Small drop for Russell 2000

Stocks narrow early losses

Bears awaken

Pre-market: Lionbridge Technologies beats expectations

Cutera Inc. stocks falls on revised ’07 guidance

Monday after hours

New Dow record as Russell 2000 falls

Stereotaxis with new tech development

Wall Street opens flat

Pre-market: Cell Therapeutics gets fast track

Avanex Corp tops small-cap volume leaders

Stocks turn flat

Pre-market: ISTA Pharmaceuticals denied by FDA

Avanex Corp. leads small-cap most-actives

Russell 2000 maintains momentum

Artes Medical announces Q1 loss

Russell 2000 looks up

Small-cap stocks open flat

Wednesday after hours

Wednesday's small-cap volume leaders

Cavium Networks most active small-cap

Russell 2000 stays strong

Nabi climbs on positive trial results of nicotine vaccine

Voxware tops small-cap percentage gainers

Pre-market: Hirsch tripled Q1 profit

Oscient Pharmaceuticals most active small cap in pre-market trading

Small caps narrow losses

NeuroMetrix reports loss in Q1

Acusphere most actively traded small cap

Pre-market: Microsoft to buy 24/7 Real Media?

Inspire Pharma stock hits new high on FDA nod

Enpath Medical leads small-cap percentage gainers

Russell sags as Enpath soars on takeover news

Pre-market: Inspire Pharmaceuticals gets FDA nod

Ionatron tops small-cap most actives

Russell slips as Dow again looks to record

Alexza Pharma up on public offering

Monolithic Power Systems leads small-cap percentage gainers

Pre-market: MDI, Inc. gets contract from US Navy

Cell Therapeutics tops pre-market small-cap most actives

Dow poised for new record

Trinity Biotech up on Q1 profit rise

Columbia Labs most active small-cap

La Jolla Pharma up on international patent grants

Pre-market: CyberOptics meets 3Q expectations

LJ International leads pre-market small-cap most actives

Record close for Russell 2000, Dow

Small gains across the board

Poniard Pharmaceuticals rises on public offering news

BioDelivery Sciences soars on positive trial results

Pre-market: DXP Enterprises posts strong quarter

CV Therapeutics leads pre-market small-cap most-actives

Introgen gets boost as cancer therapy advances

NitroMed: Trash or treasure?

Housing data lowers stocks

Pre-market: Omnicell falls on lower net income

Pre-market: NMT Medical gets study approval

Biopure low stock price prompts transfer on Nasdaq exchanges

The rally continues

U.S. stocks open strongly higher

Pre-market: EpiCept Corporation up on drug trial news

Thursday after hours

Newsletter Watch: Biotech bets

Neurochem falls after locking drug data

Monogram BioSciences hits new high on drug approval anticipation

Small-cap percentage gainers

Avanir continues rising while Russell sags

Pre-market: NeoPharm streamlines

Wednesday after hours

Avanir doubles on positive drug trial

Dow reaches for a record

Tech sector hurts stocks

Pre-market: Introgen rises on positive drug results

Tuesday after hours

Russell lags as Dow nears record

Stocks stay steady

Telik shares Jump on positive cancer therapy results

Pre-market: Nanogen submits kit to the FDA

Antigenics shares soar on positive cancer drug results

Pre-market: Progen speeds up drug development

Ariad files counter-claim against Amgen, Wyeth

Friday after hours

Two in a row for small caps

Indices looking up

Dyax hits new high on clinical trial results

SurModics expands relationship with St. Jude’s

Dyaxskyrockets on trial results

Thursday after hours

Russell 2000 rebounds

Pre-market: Parlux Fragrances receives extension from Nasdaq

Russell 2000 continues slide

Oscient Pharmaceuticals expects to double revenue

Pre-market: Mitcham down on profit decline

Cell Genesys to sell shares, prices tumble

Nuvelo leads small-cap pre-market trading

Tuesday after hours

Small rise for the Russell 2000

Synergetics up on lawsuit settlement

Russell 2000 edges up

New “buy” rating gives La Jolla Pharmaceutical stock a boost

Stocks are rising

Pre-market: Adolor down on poor drug results

Adolor tanks on negative trial results of bowel disorder drug

Memory Pharmaceuticals advances on trial of Alzheimer’s drug

Thursday after hours

Encorium Group inks $4.7 in new business

Stocks mixed

Factory orders lower stocks